Registry for advanced endoscopic procedures
Advanced Endo-therapeutic Procedure : Registry-based Observational Study
This study is collecting information from patients who are having advanced endoscopy procedures for gastrointestinal diseases to see how well these treatments work and improve patient care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre hospitalier de l'Université de Montréal (CHUM) Academic / other |
| Locations | 1 site (Montreal, Quebec) |
| Trial ID | NCT04117100 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on advanced therapeutic endoscopy procedures aimed at treating gastrointestinal diseases such as Zenker diverticulum, polyps of the colon, and colorectal cancer. Conducted at the Centre Hospitalier de l'Université de Montréal, the study aims to improve the quality of advanced endotherapeutic practices by collecting and analyzing data from patients undergoing procedures like endoscopic mucosal resection and per oral endoscopic myotomy. The data will be gathered prospectively and stored in a secure electronic registry to assess the effectiveness and quality of these minimally invasive treatments.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old who are scheduled for elective advanced therapeutic endoscopy procedures.
Not a fit: Patients with coagulopathy, poor general health, or those unable to provide informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the quality and accessibility of minimally invasive treatments for gastrointestinal diseases.
How similar studies have performed: Other studies have shown promising results with advanced endoscopic techniques, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \>18 years * Presenting for an elective advanced therapeutic endoscopy (ESD, EMR, advanced polypectomy, POEM or Zenker treatment) * Signed informed consent form Exclusion Criteria: * Patients that are not capable understanding the trial and patients without consent. * Patients with coagulopathy * Patient with poor general health defined as an American Society of Anesthesiologists class greater than three * Pregnancy
Where this trial is running
Montreal, Quebec
- Centre Hospitalier Universitaire de Montréal (CHUM) — Montreal, Quebec, Canada (Recruiting)
Study contacts
- Principal investigator: Daniel von Renteln, MD,PhD — Centre Hospitalier Universitaire de Montréal (CHUM)
- Study coordinator: Daniel von Renteln, MD, PhD
- Email: daniel.von.renteln.med@ssss.gouv.qc.ca
- Phone: 514-890-8000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.